Although a series of previous articles have revealed the potential value of flavoproteins and their interacting proteins in cancer prognosis prediction, such as CTTN, SRC, and GPD2, using the combination of flavoproteins and their interacting proteins in predicting ESCC prognosis has not been elucidated clearly. This evidence concerns the gene GPD2 and cancer.